1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potentiation of cytotoxic agents against human tumors in mice by ZD1839 (IressaTM), an inhibitor of EGFR tyrosine kinase, does not require high levels of expression of EGFR
    Meeting Abstract

    Sirotnak, F. M.; Zakowski, M. F.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Antibody to VEGF slows growth of an androgen-independent xenograft model of prostate cancer
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Scher, H. I.; Maiese, K. M.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • In vivo 19F nuclear magnetic resonance measurements of enhanced conversion of 5FU to fluoronucleotides after UPRT gene transduction
    Meeting Abstract

    Koutcher, J. A.; Matei, C.; Dubrovin, M.; Zakian, K.; Sadelain, M.; Tjuvajev, J. G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • 31P NMR studies of the effect of a redox cycling radiation sensitizer on tumor metabolism
    Meeting Abstract

    Magda, D.; Xu, S.; Gerasimchuk, N.; Lepp, C.; Zakian, K.; Chen, Y.; Koutcher, J. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Marked enhancement of radiotherapy (XRT)-induced tumor regressions by AN NAD antagonist, 6-aminonicotinamide (6-AN)
    Meeting Abstract

    Martin, D. S.; Matei, C. M.; Koutcher, J. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Anti-tumor activity of Apo2 ligand (TRAIL) in androgen-dependent and androgen-independent human prostate cancer xenograft models
    Meeting Abstract

    Maiese, K. M.; Scher, H. I.; Fox, W. D.; Higgins, B.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Ifosfamide, paclitaxel, and cisplatin (ITP) in urothelial cancer: The Memorial Sloan-Kettering Cancer Center experience with ITP as a single regimen and preceded by doxorubicin and gemcitabine (AG) in a dose-dense sequenced approach
    Meeting Abstract

    Bajorin, D. F.; McCaffrey, J. A.; Dodd, P.; Hilton, S.; Mazumdar, M.; Donat, S.; Herr, H.; Higgins, G.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Risk-adapted therapy/good-risk patients
    Book Section

    Bajorin, D. F.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Coffey, D. S.; Miles, B. J. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 2nd ed (2000)

    Fulltext@MSK | Save
  • Adjuvant and neoadjuvant chemotherapy for invasive urothelial carcinoma
    Book Section

    McCaffrey, J. A.; Bajorin, D. F.
    In Vogelzang, N. J.; Scardino, P. T.; Shipley, W. U.; Coffey, D. S.; Miles, B. J. (Eds.) Comprehensive Textbook of Genitourinary Oncology. 2nd ed (2000)

    Fulltext@MSK | Save